US EditionNeurocrine Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Neurocrine Biosciences will webcast its presentation to update investors on its neuroscience portfolio and mission to relieve patient suffering at a major healthcare event.
- On Monday, January 12, 2026, Neurocrine Biosciences, Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. Pacific Time, with a live webcast on its Investors webpage.
- CEO Andy Doraiswamy will highlight Neurocrine Biosciences, Inc. growth and commercial momentum, spotlighting Dayspring non‑pneumatic compression treatment and the company pipeline and clinical research.
- Company filings warn that Neurocrine Biosciences' press release includes forward‑looking statements and cautions readers not to place undue reliance, noting presentation dates and times may change.
- The conference gives an opportunity to engage the global investment and healthcare community and demonstrate company strategy and execution to investors and stakeholders.
- Among other presenters, the conference, scheduled for January 12–15, 2026, in San Francisco, includes Xenon Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., and Astellas Pharma Inc., highlighting broad industry participation.
69 Articles
69 Articles
The Billings Gazette
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
PALO ALTO, Calif., Jan. 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that senior management will present at the 44th Annual J.P. Morgan…
Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will present at the 44th…
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESS Newswire / January 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the J.P. Morgan 2026 Healthcare Conference on Wednesday, January…
Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference
INCHEON, South Korea, Jan. 6, 2026 /PRNewswire/ -- Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today announced that Jin-Seok Seo, Chief Executive Officer and Hyuk-Jae Lee, Senior Executive Vice President at Celltrion, will present at the 44th Annual J.P.…
Montana Standard
Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference
TOKYO, Jan. 6, 2026 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, Calif. As…
Coverage Details
Bias Distribution
- 64% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium